PMID- 31061613
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220408
IS  - 1319-0164 (Print)
IS  - 2213-7475 (Electronic)
IS  - 1319-0164 (Linking)
VI  - 27
IP  - 4
DP  - 2019 May
TI  - Evaluation of community pharmacists' knowledge about drug-drug interaction in 
      Central Saudi Arabia.
PG  - 463-466
LID - 10.1016/j.jsps.2019.01.008 [doi]
AB  - INTRODUCTION: Although all implemented and ongoing initiatives, drug-drug 
      interactions (DDIs) are still a global problem. Most published studies about DDIs 
      in Saudi Arabia are carried out in hospital settings. In addition, assessing the 
      knowledge of drug interactions in Saudi Arabia is limited. The aim of our study 
      is to evaluate the knowledge of potential common drug-drug interactions among 
      community pharmacists particularly in Saudi Arabia. METHODOLOGY: A 
      crosses-sectional study utilizing a self- administered questionnaire was 
      conducted among community pharmacy in Riyadh city Saudi Arabia. DDIs' knowledge 
      was assessed by 26 drug pairs. Community pharmacists were asked to select the 
      DDIs as "contraindication", "may be used together with monitoring", "no 
      interaction" and "not sure". RESULTS: A total of 283 of community pharmacists 
      completed the survey with response rate of 80.9%. Among the 26 drug pairs only 5 
      of them were identified correctly by most of the participants. To add more 3 out 
      of the 5 pairs had a cutoff of less than 10% between the correct and wrong 
      answer, meaning there still a majority that couldn't identify the correct answer. 
      All the 26 pairs had a statistically significant difference between the correct 
      and incorrect answer. CONCLUSION: The results of this study showed that knowledge 
      of community pharmacists about DDIs was inadequate. Community pharmacist should 
      have specific courses in drug interactions to cover the most possible 
      interactions that can be seen in this setting.
FAU - Alrabiah, Ziyad
AU  - Alrabiah Z
AD  - Department of Clinical Pharmacy, College of Pharmacy, King Saud University, 
      Riyadh, Saudi Arabia.
FAU - Alhossan, Abdulaziz
AU  - Alhossan A
AD  - Department of Clinical Pharmacy, College of Pharmacy, King Saud University, 
      Riyadh, Saudi Arabia.
FAU - Alghadeer, Sultan M
AU  - Alghadeer SM
AD  - Department of Clinical Pharmacy, College of Pharmacy, King Saud University, 
      Riyadh, Saudi Arabia.
FAU - Wajid, Syed
AU  - Wajid S
AD  - Department of Clinical Pharmacy, College of Pharmacy, King Saud University, 
      Riyadh, Saudi Arabia.
FAU - Babelghaith, Salmeen D
AU  - Babelghaith SD
AD  - Department of Clinical Pharmacy, College of Pharmacy, King Saud University, 
      Riyadh, Saudi Arabia.
FAU - Al-Arifi, Mohamed N
AU  - Al-Arifi MN
AD  - Department of Clinical Pharmacy, College of Pharmacy, King Saud University, 
      Riyadh, Saudi Arabia.
LA  - eng
PT  - Journal Article
DEP - 20190107
PL  - Saudi Arabia
TA  - Saudi Pharm J
JT  - Saudi pharmaceutical journal : SPJ : the official publication of the Saudi 
      Pharmaceutical Society
JID - 9705695
PMC - PMC6488823
OTO - NOTNLM
OT  - Community pharmacist
OT  - Drug-drug interaction
EDAT- 2019/05/08 06:00
MHDA- 2019/05/08 06:01
PMCR- 2019/01/07
CRDT- 2019/05/08 06:00
PHST- 2018/03/13 00:00 [received]
PHST- 2019/01/05 00:00 [accepted]
PHST- 2019/05/08 06:00 [entrez]
PHST- 2019/05/08 06:00 [pubmed]
PHST- 2019/05/08 06:01 [medline]
PHST- 2019/01/07 00:00 [pmc-release]
AID - S1319-0164(19)30009-X [pii]
AID - 10.1016/j.jsps.2019.01.008 [doi]
PST - ppublish
SO  - Saudi Pharm J. 2019 May;27(4):463-466. doi: 10.1016/j.jsps.2019.01.008. Epub 2019 
      Jan 7.